Keyphrases
Rheumatoid Arthritis
98%
Osteoarthritis
70%
Mesenchymal Stromal Cells
51%
Acute Respiratory Distress Syndrome
38%
Knee Osteoarthritis
38%
Human Umbilical Cord Mesenchymal Stromal Cells
38%
Early Rheumatoid Arthritis
38%
Mesenchymal Stem Cells
31%
Tocilizumab
30%
Chondrocytes
29%
Intensive Care Medicine
24%
Remission Induction
24%
Matrix Metalloproteinase 13 (MMP13)
23%
Matrix Remodeling
22%
Adipose-derived Stromal Cells
21%
Chronic Periodontitis
21%
Phase II Trial
19%
Early Recognition
19%
Mesenchymal Stem Cell Therapy
19%
Early Treatment
19%
Endometrial Stem Cells
19%
Rat Aorta
19%
Neutropenia
19%
Aorta
19%
Rheumatic Diseases
19%
Phenylephrine
19%
Cotransporter
19%
Biologic Disease-modifying Antirheumatic Drugs
19%
Health Technology
19%
Cryopreserved
19%
Smartphone
19%
High Dose
19%
Primary Healthcare Centers
19%
Non-diabetic
19%
Knee
19%
Dialysis
19%
Systemic Effects
19%
Na +
19%
Clinical Grade
19%
Disease Activity
19%
Circulating Immune Cells
19%
Anti-inflammatory Phenotype
19%
Self-assessment
19%
Rheumatologic Diseases
19%
MiR-24
19%
Terminal Differentiation
19%
Cartilage Tissue
19%
Memory T Cell Response
19%
Clinical Trials
19%
Gender Differences
19%
Medicine and Dentistry
Osteoarthritis
53%
Mesenchymal Stem Cell
53%
Umbilical Cord
38%
Knee Osteoarthritis
38%
Rheumatoid Arthritis
38%
Inflammatory Arthritis
38%
Disease
38%
Hemodialysis
32%
Clinical Trial
24%
Adipose Tissue
20%
Mesenchymal Stem Cell Transplantation
19%
Diabetes Mellitus
19%
Immunocompetent Cell
19%
Tocilizumab
19%
Stromal Cell
19%
Acute Respiratory Distress Syndrome
19%
Homeostasis
19%
Case-Control Study
19%
Vincristine
19%
Intensive Care Medicine
19%
Thrombotic Thrombocytopenic Purpura
19%
Knee
19%
Acute Renal Failure
19%
Neuropilin 1
19%
Peripheral Arterial Tonometry
19%
Eosinophilic Fasciitis
19%
Gingivitis
19%
Restylane
19%
Anti-Inflammatory Drug
19%
Collagenase 3
19%
Cartilage
19%
Gestational Age
19%
Drug Megadose
14%
Low Drug Dose
14%
Nephropathy
12%
Primary Health Care
12%
Thrombocytopenia
12%
Intra-Articular Injection
11%
Tumor Necrosis Factor
9%
Sepsis
9%
Patient Referral
9%
Knee Joint
9%
Chondrocyte
9%
Western Ontario and McMaster Universities Osteoarthritis Index
9%
Cell Therapy
8%
Arterial Stiffness
8%
Triamcinolone
7%
Immunomodulation
6%
Morning Stiffness
6%
Hematocrit
6%
Immunology and Microbiology
Inflammatory Arthritis
100%
Mesenchymal Stem Cell
87%
Osteoarthritis
48%
Knee
38%
Umbilical Cord
29%
Immunocompetent Cell
23%
Periodontitis
21%
Rheumatic Disease
19%
Disease-Modifying Antirheumatic Drug
19%
Tocilizumab
19%
Self Evaluation
19%
Grip Strength
19%
Mesenchymal Stem Cell Transplantation
19%
Adipose Tissue
19%
Memory T Cell
19%
Solution and Solubility
19%
Gingivitis
19%
Drug Megadose
16%
Low Drug Dose
16%
Immune Response
13%
Biological Functions
12%
Optimal Drug Dose
9%
Systemic Lupus Erythematosus
9%
COVID-19
9%
Methotrexate
9%
Autoimmune Disease
9%
Regulatory T Cell
9%
Power Grip
8%
Immunomodulation
8%
Pathogen Clearance
6%
Lung Mechanics
6%
Cryopreservation
6%
Medline
6%
Collagen Fiber
6%
Elastic Fiber
6%
C57BL 6 Mouse
6%
Mediator
6%
Abatacept
6%
Infliximab
6%
Animal Cell
6%
Stem Cell
6%
Escherichia coli
6%
